Olaparib in Patients With Metastatic Prostate Cancer With BRCA1 / 2 Mutation: Results From the TAPUR Study.
Eddy Shih-Hsin YangSusan HalabiMichael RotheElizabeth Garrett-MayerPam K MangatEvan PisickElie G DibEarle F BurgessMichael ZakemNitin RohatgiMehmet A BilenRaegan O'LoneGina N GranthamRichard L SchilskyPublished in: JCO precision oncology (2023)
-mutated prostate cancer.
Keyphrases